By Ed Frankl

Novartis AG on Tuesday confirmed that it would cut jobs as part of a wide-ranging restructuring aimed at saving $1 billion by 2024.

The Swiss healthcare company said last week that it would integrate its pharmaceuticals and oncology units into two medicines units--one for the U.S. and one that focuses on the international market.

"These efficiencies will come through leaner structures and will inevitably lead to roles being impacted," a spokesman told Dow Jones Newswires on Tuesday.

"At this time it is too early to indicate any specific numbers," he added.

This comes after Swiss daily Tages-Anzeiger reported that Novartis would cut thousands of jobs, including more than 100 at sites in Switzerland, citing unnamed sources.

Novartis's new structure is expected to be in place and operational by end of 2022, the spokesman said.

Write to Ed Frankl at edward.frankl@dowjones.com

(END) Dow Jones Newswires

April 12, 2022 06:06 ET (10:06 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.
Novartis (NYSE:NVS)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024 Haga Click aquí para más Gráficas Novartis.
Novartis (NYSE:NVS)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024 Haga Click aquí para más Gráficas Novartis.